HEALTH● LOW1h ago · Oct 12, 2026, 9:16 PM
J&J long-term Tremfya data demonstrates Crohn's remission through three years
Seeking Alpha Tech · global
Long-term data for J&J's drug Tremfya shows sustained remission for Crohn's disease patients over three years. This represents a significant positive development in the treatment of Crohn's disease.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH48m agoWhat we know about Pope Leo XIV's planned lung operation this weekFrance 24 [en]HEALTH1h agoNigeria records 268 Lassa fever deaths as fatality rate rises to 23.6% – NCDCPremium TimesHEALTH2h agoKaduna has mainstreamed mental health, says Uba SaniPremium TimesHEALTH2h agoPennsylvania reports its sixth measles death this year. RFK Jr’s CDC still says it’s twoThe Independent World